Search Results
Aug 03, 2026, 10:30 ET Tumor Ablation Market worth $1.89 billion by 2031 - Exclusive Report by MarketsandMarkets™
hospitals and specialized clinics. Moreover, the presence of key players in the medical devices industry in the region, which are continuously involved in R&D to develop advanced ablation systems, boosts market growth.Key PlayersLeading players in the
More news about: MarketsandMarkets
Aug 03, 2026, 10:13 ET Creating Longer AI Videos Is Still Difficult. Dreamina, the Tool of AI Video Maker, Launches Seedance 2.5 with 30-Second Generation and 50 Reference Inputs
changes are needed, creators can adjust selected parts instead of rebuilding the entire video. Features including local editing, green screen support and 3D workflow compatibility help teams refine content while keeping the original creative direction.For ecommerce teams, this means product images can
More news about: Dreamina
Aug 03, 2026, 09:21 ET As Students Return to School, MADD Calls on Families and Schools to Start Prevention Conversations Early
academically—it's also an opportunity to help them build the skills and confidence needed to make safe decisions both inside and outside the classroom," said Stacey D. Stewart, Chief Executive Officer of MADD. "Young people today face a complex landscape of influences and pressures. Our prevention programs provide schools,
More news about: Mothers Against Drunk Driving (MADD)
Aug 03, 2026, 09:14 ET Dreamina Launches Seedance 2.5, the Tool of AI Video Generation That Reduces Clip Stitching, Visual Drift and Rework
affected area while keeping the rest of the video in place.The workflow also supports:Green-screen post-production 3D white-model control Blender and Maya assets Multiple versions based on the same source materials Together, these editing
More news about: Dreamina
Aug 03, 2026, 09:01 ET d-Matrix Acquires Wallaroo.ai to Speed up Deployment of Heterogeneous AI Inference Workloads
future together."d-Matrix Accelerates Momentumd-Matrix continues to expand ecosystem collaboration with leading inference providers, offering customers the ability to choose the inference serving solution for their business needs.Wallaroo joins d-Matrix during a period of accelerating
More news about: d-Matrix
Aug 03, 2026, 09:00 ET Beyond Type 1, San Diego Padres and King of the Hill Foundation Expand Type 1 Diabetes Early Detection Efforts with Free Screening at Petco Park
welcomed more than 800 attendees, with over 200 eligible participants completing T1D autoantibody screening. The simple blood test looks for diabetes-related autoantibodies that may indicate an increased risk of developing T1D before symptoms appear. Those screened will receive results in approximately four
More news about: Beyond Type 1
Aug 03, 2026, 09:00 ET Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform
Aug. 3, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced continued expansion of its intellectual property portfolio, which now comprises seven patent families covering compositions of matter,
More news about: Decoy Therapeutics, Inc
Aug 03, 2026, 09:00 ET Elong Power Holding Limited Announces Pricing of US$1.38 Million Public Offering
2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D, sales and scenario-oriented system solutions of lithium-ion battery energy storage systems, today announced the pricing of its registered offering
More news about: Elong Power Holding Limited
Aug 03, 2026, 09:00 ET BOTOX® (toxina botulínica A) recebe aprovação da Anvisa para uso no músculo platisma
placebo-controlled phase 3 trial. J Am Acad Dermatol. 2025 Feb;92(2):285-291.Trindade de Almeida A, De Boulle K, Lorenc ZP, Carruthers J, Braz A, Bertossi D, Dimitrijevic E, Shimoga S, Hopfinger R. Platysma Prominence: Review and Expert Analysis of Clinical Presentation, Burden, and Treatment Considerations.
More news about: Allergan
Aug 03, 2026, 09:00 ET Ritual's Essential Prenatal--the #1 best-selling prenatal backed by its own human clinical trial--is now available at Costco locations nationwide.
needs before and during pregnancy, including Omega-3 DHA, Choline, and bioavailable Methylated Folate to support fetal brain development, as well as D3, K2, Magnesium, and Boron to support bone health.* Plus, it features patented nutrient-delivery technology with a nested, delayed release capsule, and
More news about: Ritual
Aug 03, 2026, 09:00 ET Rennova® apresenta soluções para compor protocolos integrados e individualizados para pacientes com lipedema
TechA Rennova® Tech é a marca de tecnologia da Rennova®, focada em redefinir o mercado de equipamentos estéticos. Nascida da liderança em P&D 100% nacional, design e excelência em qualidade, a marca oferece um ecossistema completo de soluções para o mercado estético, sob o conceito de "Liberdade
More news about: Rennova
Aug 03, 2026, 08:55 ET Guidewire Introduces Qusar Release to Help Insurers Build and Control AI Agents
P&C insurers.We are proud of our unparalleled implementation record, with 1,700+ successful projects supported by the industry's largest R&D team and SI partner ecosystem. Our marketplace represents the largest partner community in P&C, where customers can access hundreds of applications
More news about: Guidewire Software
Aug 03, 2026, 08:55 ET Guidewire Introduces Qusar Release to Help Insurers Build and Control AI Agents
P&C insurers.We are proud of our unparalleled implementation record, with 1,700+ successful projects supported by the industry's largest R&D team and SI partner ecosystem. Our marketplace represents the largest partner community in P&C, where customers can access hundreds of applications
More news about: Guidewire Software
Aug 03, 2026, 08:43 ET Los Angeles Pop Artist ALYA Finds Hope in New Cinematic Single 'Believer'
connecting audiences through themes of hope, humanity, and empowerment. She has collaborated with artists including Eric Clapton, Erica Campbell, and D Smoke, and her ongoing "Hope" project, including Hope: The Sequel, has grown into a movement centered on kindness and collective good."Believer"
More news about: ALYA
Aug 03, 2026, 08:42 ET Seoul National University of Science and Technology Develops an AI Framework for Long-Term Bridge Damage Monitoring
Monitoring on April 27, 2026.This study enables long-term monitoring by combining artificial intelligence with three-dimensional (3D) bridge reconstruction. The 3D model of the bridge is built using images captured during the initial inspection. Images from subsequent inspections are then automatically
More news about: Seoul National University of Science and Technology
Aug 03, 2026, 08:34 ET Sonorous Neurovascular Achieves First Canadian Enrollment in B-SILENT Study, Expanding Global Momentum
www.sonorousnv.com.Contact:James D. Nonato, Vice PresidentSonorous NeurovascularEmail: [email protected] Phone:
More news about: Sonorous Neurovascular
Aug 03, 2026, 08:32 ET FAIR Health NSA and Allowed Data Products May Be Introduced in IDR Proceedings to Support Offers, and IDR Entities May Consult FAIR Health Data to Validate Party Submissions
year. A national Qualified Entity certified by CMS, FAIR Health also receives all claims for individuals enrolled in traditional Medicare Parts A, B and D. As a testament to its reliability and objectivity, FAIR Health's data products—including pricing benchmarks and custom analytics—are widely used by commercial
More news about: FAIR Health
Aug 03, 2026, 08:30 ET Esquire Financial Holdings, Inc. Completes Acquisition of Signature Bancorporation, Inc. on August 1, 2026
name "Signature, a division of Esquire Bank" (the "Division"). Michael G. O'Rourke will serve as President of the Division. Kevin P. Bastuga and Bryan D. Duncan will each serve as Executive Vice Presidents of the Division.Michael G. O'Rourke, President of Signature, a division of Esquire Bank, added,
More news about: Esquire Financial Holdings, Inc.
Aug 03, 2026, 08:17 ET Genezen and the Raiden Science Foundation Announce Partnership for AAV9 Gene Replacement Therapy for UBA5 Clinical Trial
gene replacement therapy for UBA5 disorder. This partnership marks a major milestone for RSF, moving its UBA5 gene therapy program from four years of R&D into clinical manufacturing and one step closer to the first-in-human clinical trial for this devastating disorder.
More news about: Genezen
Aug 03, 2026, 08:01 ET NextPlat to Release Second Quarter 2026 Results on Thursday, August 13, 2026
https://viavid.webcasts.com/starthere.jsp?ei=1770457&tp_key=6a139162d1Please call the conference telephone number 5-10 minutes prior to the start time.
More news about: NextPlat Corp.
Aug 03, 2026, 08:00 ET PENSKE INVESTIGATION ALERT: Kaskela Law Firm is Investigating Penske Automotive Group, Inc. (PAG) and Encourages PAG Stockholders to Contact the Firm
the company's shares and potentially shortchanges PAG investors.Penske Automotive shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email at [email protected]
More news about: Kaskela Law LLC
Aug 03, 2026, 08:00 ET Unhappy With The $35.00 Per Share Buyout Price? Contact Kaskela Law to Discuss Your Legal Rights and Options with Respect to the Buyout - DSGR
securities laws in agreeing to the $35.00 per share buyout price from LKCM Headwater. DSG shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email at [email protected],
More news about: Kaskela Law LLC
Aug 03, 2026, 08:00 ET Unhappy With The $14.25 Per Share Buyout Price? Contact Kaskela Law to Discuss Your Legal Rights and Options with Respect to the Buyout - UTZ
maintaining price targets for Utz shares well above the agreed-to buyout price.Utz shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email at [email protected],
More news about: Kaskela Law LLC
Aug 03, 2026, 08:00 ET cAMPfield Strengthens Leadership Team with Key Executive Appointments, Including Graham Heap, MD, PhD as President, R&D, to Advance Prifemilast into Global Phase 2 Development for Inflammatory Bowel Disease
Graham Heap, MD, PhD joins as President, Research and Development (R&D), with responsibility for leading all the Company's research and development activities. Ezequiel Neimark, MD joins as Head of Clinical Development
More news about: cAMPfield Therapeutics
Aug 03, 2026, 08:00 ET Broadcom Inc. to Announce Third Quarter Fiscal Year 2026 Financial Results on Wednesday, September 2, 2026
develops, and supplies semiconductors and infrastructure software for global organizations' complex, mission-critical needs. Broadcom combines long-term R&D investment with superb execution to deliver the best technology, at scale. Broadcom is a Delaware corporation headquartered in Palo Alto, CA. For more
More news about: Broadcom Inc.